Are you a chemistry or biochemistry student looking for a ‘year in industry’ placement in interdisciplinary drug discovery?
MRC Technology, a medical research charity, is offering a one year placement opportunity for an undergraduate within the chemistry section of our Antibody-Drug Conjugate (ADC) group, starting September 2017. The placement offers the chance to gain experience in generating and analysing the structure and properties of novel ADCs, synthetic molecules that combine antibodies with therapeutically active small molecules. Specific goals for this project will include the assessment and optimisation of a variety of conjugation methodologies and the systematic analysis of the conjugates produced in both form and function.
This work is highly interdisciplinary and would suit anyone with skills in chemistry, biochemistry or mass spec analysis, with an interest in working across all three of these areas. This placement will provide the opportunity to learn skills in analytical techniques, molecular biology and organic chemistry in an exciting and challenging environment.
The successful applicant will become a member of the cross discipline ADC project team. The student will be expected to fully participate in the team and although directly supervised by one of the experienced team members, they will find they are routinely working with a number of both chemistry and biology scientists. Regular verbal presentations of experimental results and conclusions will be given by the student to the project team and to chemistry management, and the student will be expected to maintain high quality electronic lab notebook records of their research.
Any reasonable requirements set by the student’s institution for work towards the degree course will be supported. During the placement year, at least one area of the research will be identified as suitable for any written project requirements in support of the student’s degree submission.
MRC Technology’s Centre for Therapeutics Discovery (CTD) undertakes small molecule and therapeutic antibody drug discovery against novel targets in collaboration with academic groups across the UK and the world. Based in research laboratories in Stevenage, CTD currently consists of around 75 scientists. This number includes the chemistry department of 24 scientists, who work on early stage small molecule medicinal chemistry programs and small molecule antibody conjugation strategies.
MRC Technology offers 10 student placements a year – 3 in chemistry and 7 in biology, with placements starting in early September and running for 11.5 months.
Final acceptance onto a placement position will depend on a satisfactory outcome of a medical assessment. The contracted role is Monday – Friday with some flexibility around working pattern, and the students will be expected to respond to any reasonable requests to work outside normal hours in order to achieve specific objectives.The present rate of pay for industrial placements is approximately £18,000 per annum.
It is MRCT’s policy to employ individuals on the basis of their suitability for the work to be performed and their potential for development, regardless of age, sex, race, colour, nationality, ethnic or national origin, disability, marital status, pregnancy or maternity, sexual orientation, gender reassignment, religion or belief.
To apply please email your CV and covering letter, containing details of you current course, to: firstname.lastname@example.org or by post to Recruitment, MRC Technology, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX (electronic applications preferred).
Closing date: 13 April 2017